HepVu and NASTAD Release Inaugural Viral Hepatitis Surveillance Status Report
October 25, 2022 10:32 ET
|
HepVu
ATLANTA, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Today, HepVu and NASTAD released the first-ever assessment of viral hepatitis surveillance practices across U.S. jurisdictions, showing that while public...
Global Liver Fibrosis Treatment Market to Surpass US$ 33.4 Billion by 2030, Says Coherent Market Insights (CMI)
August 08, 2022 09:10 ET
|
CMI
Seattle, Aug. 08, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global liver fibrosis treatment market is estimated to be valued at US$ 14.7 billion in 2022 and is expected to...
HepVu Launches County-Level Hepatitis C-Related Mortality Data and Maps Visualizing Hepatitis C’s Impact on Americans at the Local-Level
March 03, 2021 12:44 ET
|
HepVu
ATLANTA, March 03, 2021 (GLOBE NEWSWIRE) -- Today, HepVu released new interactive maps visualizing U.S. county-level Hepatitis C-related mortality, illustrating how factors such as age and...
Cocrystal Pharma to Present at the H.C. Wainwright Global Life Sciences Virtual Conference
March 02, 2021 08:00 ET
|
Cocrystal Pharma, Inc.
BOTHELL, Wash., March 02, 2021 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP), (“Cocrystal” or the “Company”), a clinical-stage biotechnology company discovering and developing novel...
Cocrystal Pharma Inc.’s Structure-Based Technology has Demonstrated Broad Utility in Development of Antivirals
February 13, 2020 08:30 ET
|
Cocrystal Pharma, Inc.
– Positive preclinical and clinical data obtained to date in hepatitis C, influenza and norovirus programs bolster confidence in potential of our platform to address additional viral diseases,...
Actor Ernie Hudson to serve as national spokesperson for Think About the Link
December 16, 2019 12:48 ET
|
Prevent Cancer Foundation
Alexandria, Va., Dec. 16, 2019 (GLOBE NEWSWIRE) -- Ernie Hudson is best known for his role in the 1984 cult classic, Ghostbusters; however few fans know him as two-time cancer survivor. Hudson was...
Hearts from Hepatitis C patients are safe to transplant, research shows
April 04, 2019 10:30 ET
|
International Society for Heart & Lung Transplantation
Orlando, Fla., April 04, 2019 (GLOBE NEWSWIRE) -- A growing body of research suggests that heart transplantation from donors with active Hepatitis C (HCV) is safe – and that the virus successfully...
Cocrystal Pharma Completes Patient Enrollment in Phase 2a Study Evaluating CC-31244 for Ultra-Short Treatment of Hepatitis C
September 20, 2018 08:00 ET
|
Cocrystal Pharma, Inc.
ATLANTA, GA and BOTHELL, WA, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and...
GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS
August 08, 2018 02:00 ET
|
Genedrive PLC
GENEDRIVE PARTNERS WITH FIND TO EVALUATE A MOLECULAR DIAGNOSTIC KIT FOR HEPATITIS C VIRUS IN DECENTRALISED SETTINGS Evaluation studies of the...
Cocrystal Pharma Receives FDA Clearance to Initiate Phase 2a Clinical Study Evaluating CC-31244 for the Treatment of Hepatitis C Virus
April 03, 2018 08:00 ET
|
Cocrystal Pharma, Inc.
– Company on track to commence patient enrollment and dosing in Q2 2018 – – Topline data from Phase 2a study expected in Q4 2018 – ATLANTA, GA and BOTHELL, WA, April 03,...